Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

XIENCE PRIME Everolimus Eluting Coronary Stent Post Marketing Surveillance (PMS) in Japan

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01721096
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:28.224963+00:00
Published At
2016-07-19T00:00:00+00:00
Record Updated At
2019-12-20
Results Posted At
2016-07-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Angina", "Coronary Occlusion", "Coronary Artery Disease", "Coronary Artery Stenosis", "Myocardial Ischemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-12-20"
protocolSection.identificationModule.nctId
"NCT01721096"
protocolSection.identificationModule.officialTitle
"XIENCE PRIME Everolimus Eluting Coronary Stent Post Marketing Surveillance (PMS) in Japan"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2016-07-19"

Study condition terms

  • Angina (protocolSection.conditionsModule.conditions)
  • Coronary Occlusion (protocolSection.conditionsModule.conditions)
  • Coronary Artery Disease (protocolSection.conditionsModule.conditions)
  • Coronary Artery Stenosis (protocolSection.conditionsModule.conditions)
  • Myocardial Ischemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.